RiboX Therapeutics

RiboX | Circular RNA

Shanghai, China · Founded 2021 · $110.0M raised

Headquarters
Shanghai
Founded
2021
Business Model
B2B
Total Funding
$110.0M
Last Round
$110.0M Series B
Rounds
1

About

RiboX Therapeutics is a biotechnology company discovering and developing fully engineered circular RNA (circRNA) therapeutics, a class of RNA medicines designed to overcome the stability and durability limitations of conventional mRNA drugs. Cofounded in 2021 by Drs. Ling-Ling Chen, Dan Peer, and Weiyi Zhang, the company operates across Shanghai, Princeton (New Jersey, US), and Rehovot (Israel). In 2024 RiboX became the first company to receive FDA IND clearance for a circular RNA therapy, RXRG001, targeting radiation-induced xerostomia and hyposalivation, and has since dosed its first patient in a Phase I/IIa trial.

Summary

RiboX Therapeutics is a Biotech company based in Shanghai, China, founded in 2021. It has raised $110.0M in total across 1 round. Investors include Qiming VP, Boehringer Ingelheim Venture Fund and Vivo Capital.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries B
$110.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RiboX Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ribox-therapeutics"><img src="https://indexed.vc/api/badge/company/ribox-therapeutics" alt="RiboX Therapeutics on Indexed.vc" width="260" height="76" /></a>